In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Regeneron initiates phase II obesity clinical trial
Emisphere announces oral PTH license agreement
Novartis extends collaboration with Emisphere
Emisphere Technologies Inc. Signs Licensing Agreement with Roche to Develop Oral Formulations
Regeneron Announces VelociGene(R) Agreement with Sanofi-Aventis
Cellectis and Regeneron sign an agreement over the use of homologous recombination technology
EMISPHERE TECHONOLOGIES, INC. AND AAIPHARMA INC. ANNOUNCE ALLIANCE